Characterization of Potential Biomarkers of Eye Disease and Vision
This trial is active, not recruiting.
|Sponsor||Association for Innovation and Biomedical Research on Light and Image|
|Start date||September 2015|
|End date||December 2017|
|Trial size||100 participants|
|Trial identifier||NCT02500862, 4C-2015-08|
Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI
Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI.
time frame: 10 years
All participants at least 18 years old.
Inclusion Criteria: - Any patient followed under the normal clinical practice at AIBILI Clinical Trial Centre, and with a AIBILI signed informed consent form for data collection, Imp. 11-7-2 "Consentimento Informado para tratamento de dados". Exclusion criteria:
|Official title||Characterization of Potential Biomarkers of Eye Disease and Vision Loss.|
|Principal investigator||Maria L Ribeiro, MsC|
|Description||This is a registry study. Only patients followed under the clinical practice at AIBILI Clinical Trial Centre, and with a signed informed consent form will be included. Based on the clinical information collected under the clinical practice, and based on patients' characteristics, scientific questions will be raised and data will be collected and analysed accordingly. Any procedure performed under clinical practice that may allow for the characterization of the disease and/or for the identification of potential biomarkers will be collected and analysed.|
Call for more information